Martin Shkreli Hits Back After Sydney Students Cook His Drug On The Cheap
SUBSCRIBE FREE TO PEDESTRIAN DAILY
- Reconsider your former company's much-maligned pricing policies, or;
- Pick holes in the high school kids' achievement while stoking a futile and trollish flamewar?
If you're Martin Shkreli - who bloody else, really - the answer is most certainly 2.
The former Turing Pharmaceuticals CEO responded to a user who'd posted the original Sydney Morning Herald article on the matter by implying just about anyone can cook up small batches of life-saving medication on the cheap:
@nedavanovac lol how is that showing anyone up? almost any drug can be made at small scale for a low price. glad it makes u feel good tho.— Martin Shkreli (@MartinShkreli) December 1, 2016
@Scottyt2Hottie uh learning synthesis isn't innovation— Martin Shkreli (@MartinShkreli) December 1, 2016
@Scottyt2Hottie yea uh anyone can make any drug it is pretty ez— Martin Shkreli (@MartinShkreli) December 1, 2016
In response to commenters who asked why the hell Daraprim costs so much when Sydney Grammar just proved it can be created relatively cheaply, Shkreli leaned on the costs associated with getting drugs approved for human use:
@Uberpatroit theyre getting fda approval? cool!— Martin Shkreli (@MartinShkreli) December 1, 2016
@HarrisJoseph16 uh you know more goes into 'manufacturing a drug' than making 5mg at lab scale with no QA right?— Martin Shkreli (@MartinShkreli) December 1, 2016
In fairness, Shkreli did cede that he's "happy the kids are learning science," but "the inability for people to understand how drugs come to be made is frustrating."
The inability for most of his detractors to understand why American Daraprim-dependant patients without health insurance are forced to fork out triple-figures per tablet is frustrating, too. But hey.
Source: Martin Shkreli / Twitter.